STIM Neuronetics, Inc.

NASDAQ
$2.74

Neuronetics, Inc. (STIM) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.4% since its last earnings release on August 11, 2026.

Neuronetics Beat Consensus Estimates, Narrows Guidance
Tuesday, August 11, 2026 · 7:50 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:50 AM ET
Earnings Whisper
-
vs ($0.08)
Rev est $40.7M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.07

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Neuronetics, Inc.

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.